1. Home
  2. FHB vs SRRK Comparison

FHB vs SRRK Comparison

Compare FHB & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHB
  • SRRK
  • Stock Information
  • Founded
  • FHB 1858
  • SRRK 2012
  • Country
  • FHB United States
  • SRRK United States
  • Employees
  • FHB N/A
  • SRRK N/A
  • Industry
  • FHB Major Banks
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FHB Finance
  • SRRK Health Care
  • Exchange
  • FHB Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • FHB 3.0B
  • SRRK 3.0B
  • IPO Year
  • FHB 2016
  • SRRK 2018
  • Fundamental
  • Price
  • FHB $25.31
  • SRRK $41.58
  • Analyst Decision
  • FHB Sell
  • SRRK Strong Buy
  • Analyst Count
  • FHB 9
  • SRRK 11
  • Target Price
  • FHB $28.00
  • SRRK $47.30
  • AVG Volume (30 Days)
  • FHB 1.3M
  • SRRK 2.1M
  • Earning Date
  • FHB 10-24-2025
  • SRRK 11-14-2025
  • Dividend Yield
  • FHB 4.22%
  • SRRK N/A
  • EPS Growth
  • FHB 17.02
  • SRRK N/A
  • EPS
  • FHB 2.05
  • SRRK N/A
  • Revenue
  • FHB $824,314,000.00
  • SRRK N/A
  • Revenue This Year
  • FHB $12.21
  • SRRK N/A
  • Revenue Next Year
  • FHB $2.25
  • SRRK $1,987.65
  • P/E Ratio
  • FHB $12.04
  • SRRK N/A
  • Revenue Growth
  • FHB 1.80
  • SRRK N/A
  • 52 Week Low
  • FHB $20.32
  • SRRK $22.71
  • 52 Week High
  • FHB $28.80
  • SRRK $46.98
  • Technical
  • Relative Strength Index (RSI)
  • FHB 60.15
  • SRRK 69.74
  • Support Level
  • FHB $23.32
  • SRRK $37.54
  • Resistance Level
  • FHB $24.90
  • SRRK $39.50
  • Average True Range (ATR)
  • FHB 0.54
  • SRRK 2.22
  • MACD
  • FHB 0.08
  • SRRK 1.24
  • Stochastic Oscillator
  • FHB 89.66
  • SRRK 86.59

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: